1 / 3

Myocarditis

Myocarditis. HFSA 2010 Recommendations. HFSA 2010 Practice Guideline Myocarditis. Recommendation 16.1 Routine use of immunosuppressive therapies is not recommended for patients with myocarditis. Strength of Evidence = A. HFSA 2010 Practice Guideline Myocarditis. Recommendation 16.2

kalin
Télécharger la présentation

Myocarditis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Myocarditis HFSA 2010 Recommendations

  2. HFSA 2010 Practice GuidelineMyocarditis • Recommendation 16.1 • Routine use of immunosuppressive therapies is not recommended for patients with myocarditis. • Strength of Evidence = A

  3. HFSA 2010 Practice GuidelineMyocarditis • Recommendation 16.2 • Endomyocardial biopsy should be considered in patients: • With an acute deterioration of cardiac function of unknown etiology who are unresponsive to medical therapy • Strength of Evidence = B

More Related